German pharmaceutical company Boehringer Ingelheim is reportedly facing more than 2,000 lawsuits in the United States. The lawsuits allege that Pradaxa is among dangerous drugs causing causing bleeding, often resulting in injury or death.
This news comes on the heels of a new Food and Drug Administration look into Pradaxa’s safety. Although the FDA has reviewed safety data on Pradaxa previously, it has now decided to compare outcomes in Pradaxa and warfarin patients.
Pradaxa is the first of a new group of alternative medications to the traditional anticoagulant, warfarin. First marketed in 2010, Pradaxa quickly came under fire as side-effect reports began to mount. Physicians have been particularly worried by the fact that, unlike warfarin, Pradaxa and other anticoagulants in the class, have no antidote. Without an antidote, bleeding is difficult or impossible to stop once it begins.
Boehringer, as well as Pfizer and Bristol-Myers Squibb — which markets a similar drug, Eliquis – and Johnson & Johnson and Bayer, manufacturer of Xarelto, are working on an antidote.
The Ohio Pradaxa attorneys at Clark, Perdue & List represent people who have been injured or have died due to bleeding caused by taking Pradaxa. If you or a loved one has been injured by Pradaxa, contact the Ohio dangerous drugs lawyers at Clark, Perdue & List.